Thermo Fisher Scientific, a global leader in scientific innovation, is sponsoring Lab of the Future Europe in Amsterdam this week, showcasing its Thermo Fisher™ Connect Platform as a transformative solution for modern laboratories. The event highlights how digital transformation and intelligent automation are reshaping life sciences and pharmaceutical research, moving beyond basic digitization to full orchestration of instruments, systems, and data. Many labs still struggle with technical debt and outdated IT infrastructure, creating inefficiencies that slow down discovery. Thermo Fisher’s Connect Platform addresses this by seamlessly integrating laboratory equipment and workflows through advanced digital and AI-powered automation. The platform enables real-time data exchange, reduces manual intervention, and creates a unified, intelligent environment that enhances productivity and reproducibility. Mark Fish, Vice President and General Manager of Digital Science and Automation Solutions at Thermo Fisher, emphasized the company’s mission: “Our goal is to help scientists achieve their objectives more efficiently, freeing them from routine tasks so they can focus on discovery, understanding, and real-world impact.” The Connect Platform embodies this vision by transforming laboratories from fragmented, siloed operations into connected, intelligent ecosystems. At the event, visitors can experience live demonstrations of the platform’s capabilities, including intelligent automation, data integration, and AI-driven insights. These features help researchers design experiments faster, manage complex workflows, and derive meaningful results from vast datasets. A key highlight of the event is Thermo Fisher’s strategic partnership with BenchSci, a leader in AI-powered life sciences research. Together, the companies are developing new AI-driven tools to accelerate experimental design and enhance R&D productivity. These innovations will help scientists make data-driven decisions faster, reduce trial-and-error cycles, and improve the success rate of research projects. Thermo Fisher Scientific, with over $40 billion in annual revenue, serves the global scientific community across a wide range of applications—from accelerating life sciences research and solving complex analytical challenges to improving patient diagnostics and developing transformative therapies. Through its leading brands—including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD—the company delivers a unique combination of cutting-edge technology, seamless procurement, and specialized services. The company’s commitment to innovation extends beyond hardware and software. By integrating AI and automation into core lab operations, Thermo Fisher is helping laboratories evolve from reactive, manual environments into proactive, intelligent systems capable of driving scientific breakthroughs at scale. While the platform’s ability to integrate and automate is now being demonstrated in real time, the company also acknowledges the broader challenges of data governance, security, and ethical AI use—issues that will continue to shape the future of lab innovation. Lab of the Future Europe offers a glimpse into how digital transformation is no longer optional but essential for scientific progress. Thermo Fisher’s Connect Platform, supported by strategic partnerships and deep technological expertise, positions laboratories to meet the demands of tomorrow’s research landscape. This event underscores a critical shift: laboratories are no longer just places where experiments happen, but intelligent hubs where data, automation, and AI converge to accelerate discovery, improve outcomes, and ultimately make the world healthier, safer, and more sustainable.